Report Detail

Chemical & Material Global Medicinal Exosomes Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4646640
  • |
  • 09 November, 2025
  • |
  • Global
  • |
  • 134 Pages
  • |
  • GIR
  • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Medicinal Exosomes market size was valued at US$ 489 million in 2024 and is forecast to a readjusted size of USD 1518 million by 2031 with a CAGR of 17.8% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Medicinal exosomes are tiny vesicles with a single-layer membrane structure that are actively secreted by cells. The aqueous core is surrounded by a lipid bilayer, and a variety of biological components such as proteins, lipids, and nucleic acids (including mRNA, miRNA, etc.) are encapsulated in its cavity or lipid bilayer. As a drug delivery carrier, medicinal exosomes can deliver drug molecules to target cells in an efficient and specific manner, providing a new idea and practical technology for targeted treatment of diseases. In the field of biotechnology, medicinal exosomes have broad application prospects. For example, exosomes can be targeted to specific cells or tissues in a cell- or tissue-specific manner for drug delivery and treatment.
This report is a detailed and comprehensive analysis for global Medicinal Exosomes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medicinal Exosomes market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2020-2031
Global Medicinal Exosomes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2020-2031
Global Medicinal Exosomes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2020-2031
Global Medicinal Exosomes market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medicinal Exosomes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medicinal Exosomes market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ExoCoBio, ASFREYA, AM BioTech Co., Ltd., Anjarium Biosciences AG, Creative Biolabs, EXO Biologics SA, Cytiva, STEMON, Exolitus, RoosterBio, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medicinal Exosomes market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Plant-derived Exosomes
Human-derived Exosomes
Market segment by Application
Arthritis
Bone Fractures
Premature Ovarian Failure
Macular Degeneration
Heart Failure
Stroke
Others
Major players covered
ExoCoBio
ASFREYA
AM BioTech Co., Ltd.
Anjarium Biosciences AG
Creative Biolabs
EXO Biologics SA
Cytiva
STEMON
Exolitus
RoosterBio, Inc.
Bioscience Institute
Capricor Therapeutics
ECHO Alotech
EVMed Pro
Anextcell
Shenzhen Beike Biotechnology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medicinal Exosomes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medicinal Exosomes, with price, sales quantity, revenue, and global market share of Medicinal Exosomes from 2020 to 2025.
Chapter 3, the Medicinal Exosomes competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medicinal Exosomes breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Medicinal Exosomes market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medicinal Exosomes.
Chapter 14 and 15, to describe Medicinal Exosomes sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medicinal Exosomes Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Plant-derived Exosomes
    • 1.3.3 Human-derived Exosomes
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medicinal Exosomes Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Arthritis
    • 1.4.3 Bone Fractures
    • 1.4.4 Premature Ovarian Failure
    • 1.4.5 Macular Degeneration
    • 1.4.6 Heart Failure
    • 1.4.7 Stroke
    • 1.4.8 Others
  • 1.5 Global Medicinal Exosomes Market Size & Forecast
    • 1.5.1 Global Medicinal Exosomes Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Medicinal Exosomes Sales Quantity (2020-2031)
    • 1.5.3 Global Medicinal Exosomes Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 ExoCoBio
    • 2.1.1 ExoCoBio Details
    • 2.1.2 ExoCoBio Major Business
    • 2.1.3 ExoCoBio Medicinal Exosomes Product and Services
    • 2.1.4 ExoCoBio Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 ExoCoBio Recent Developments/Updates
  • 2.2 ASFREYA
    • 2.2.1 ASFREYA Details
    • 2.2.2 ASFREYA Major Business
    • 2.2.3 ASFREYA Medicinal Exosomes Product and Services
    • 2.2.4 ASFREYA Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 ASFREYA Recent Developments/Updates
  • 2.3 AM BioTech Co., Ltd.
    • 2.3.1 AM BioTech Co., Ltd. Details
    • 2.3.2 AM BioTech Co., Ltd. Major Business
    • 2.3.3 AM BioTech Co., Ltd. Medicinal Exosomes Product and Services
    • 2.3.4 AM BioTech Co., Ltd. Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 AM BioTech Co., Ltd. Recent Developments/Updates
  • 2.4 Anjarium Biosciences AG
    • 2.4.1 Anjarium Biosciences AG Details
    • 2.4.2 Anjarium Biosciences AG Major Business
    • 2.4.3 Anjarium Biosciences AG Medicinal Exosomes Product and Services
    • 2.4.4 Anjarium Biosciences AG Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Anjarium Biosciences AG Recent Developments/Updates
  • 2.5 Creative Biolabs
    • 2.5.1 Creative Biolabs Details
    • 2.5.2 Creative Biolabs Major Business
    • 2.5.3 Creative Biolabs Medicinal Exosomes Product and Services
    • 2.5.4 Creative Biolabs Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Creative Biolabs Recent Developments/Updates
  • 2.6 EXO Biologics SA
    • 2.6.1 EXO Biologics SA Details
    • 2.6.2 EXO Biologics SA Major Business
    • 2.6.3 EXO Biologics SA Medicinal Exosomes Product and Services
    • 2.6.4 EXO Biologics SA Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 EXO Biologics SA Recent Developments/Updates
  • 2.7 Cytiva
    • 2.7.1 Cytiva Details
    • 2.7.2 Cytiva Major Business
    • 2.7.3 Cytiva Medicinal Exosomes Product and Services
    • 2.7.4 Cytiva Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Cytiva Recent Developments/Updates
  • 2.8 STEMON
    • 2.8.1 STEMON Details
    • 2.8.2 STEMON Major Business
    • 2.8.3 STEMON Medicinal Exosomes Product and Services
    • 2.8.4 STEMON Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 STEMON Recent Developments/Updates
  • 2.9 Exolitus
    • 2.9.1 Exolitus Details
    • 2.9.2 Exolitus Major Business
    • 2.9.3 Exolitus Medicinal Exosomes Product and Services
    • 2.9.4 Exolitus Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Exolitus Recent Developments/Updates
  • 2.10 RoosterBio, Inc.
    • 2.10.1 RoosterBio, Inc. Details
    • 2.10.2 RoosterBio, Inc. Major Business
    • 2.10.3 RoosterBio, Inc. Medicinal Exosomes Product and Services
    • 2.10.4 RoosterBio, Inc. Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 RoosterBio, Inc. Recent Developments/Updates
  • 2.11 Bioscience Institute
    • 2.11.1 Bioscience Institute Details
    • 2.11.2 Bioscience Institute Major Business
    • 2.11.3 Bioscience Institute Medicinal Exosomes Product and Services
    • 2.11.4 Bioscience Institute Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Bioscience Institute Recent Developments/Updates
  • 2.12 Capricor Therapeutics
    • 2.12.1 Capricor Therapeutics Details
    • 2.12.2 Capricor Therapeutics Major Business
    • 2.12.3 Capricor Therapeutics Medicinal Exosomes Product and Services
    • 2.12.4 Capricor Therapeutics Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Capricor Therapeutics Recent Developments/Updates
  • 2.13 ECHO Alotech
    • 2.13.1 ECHO Alotech Details
    • 2.13.2 ECHO Alotech Major Business
    • 2.13.3 ECHO Alotech Medicinal Exosomes Product and Services
    • 2.13.4 ECHO Alotech Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 ECHO Alotech Recent Developments/Updates
  • 2.14 EVMed Pro
    • 2.14.1 EVMed Pro Details
    • 2.14.2 EVMed Pro Major Business
    • 2.14.3 EVMed Pro Medicinal Exosomes Product and Services
    • 2.14.4 EVMed Pro Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 EVMed Pro Recent Developments/Updates
  • 2.15 Anextcell
    • 2.15.1 Anextcell Details
    • 2.15.2 Anextcell Major Business
    • 2.15.3 Anextcell Medicinal Exosomes Product and Services
    • 2.15.4 Anextcell Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Anextcell Recent Developments/Updates
  • 2.16 Shenzhen Beike Biotechnology Co., Ltd.
    • 2.16.1 Shenzhen Beike Biotechnology Co., Ltd. Details
    • 2.16.2 Shenzhen Beike Biotechnology Co., Ltd. Major Business
    • 2.16.3 Shenzhen Beike Biotechnology Co., Ltd. Medicinal Exosomes Product and Services
    • 2.16.4 Shenzhen Beike Biotechnology Co., Ltd. Medicinal Exosomes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Shenzhen Beike Biotechnology Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Medicinal Exosomes by Manufacturer

  • 3.1 Global Medicinal Exosomes Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Medicinal Exosomes Revenue by Manufacturer (2020-2025)
  • 3.3 Global Medicinal Exosomes Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Medicinal Exosomes by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Medicinal Exosomes Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Medicinal Exosomes Manufacturer Market Share in 2024
  • 3.5 Medicinal Exosomes Market: Overall Company Footprint Analysis
    • 3.5.1 Medicinal Exosomes Market: Region Footprint
    • 3.5.2 Medicinal Exosomes Market: Company Product Type Footprint
    • 3.5.3 Medicinal Exosomes Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medicinal Exosomes Market Size by Region
    • 4.1.1 Global Medicinal Exosomes Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Medicinal Exosomes Consumption Value by Region (2020-2031)
    • 4.1.3 Global Medicinal Exosomes Average Price by Region (2020-2031)
  • 4.2 North America Medicinal Exosomes Consumption Value (2020-2031)
  • 4.3 Europe Medicinal Exosomes Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Medicinal Exosomes Consumption Value (2020-2031)
  • 4.5 South America Medicinal Exosomes Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Medicinal Exosomes Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Medicinal Exosomes Sales Quantity by Type (2020-2031)
  • 5.2 Global Medicinal Exosomes Consumption Value by Type (2020-2031)
  • 5.3 Global Medicinal Exosomes Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Medicinal Exosomes Sales Quantity by Application (2020-2031)
  • 6.2 Global Medicinal Exosomes Consumption Value by Application (2020-2031)
  • 6.3 Global Medicinal Exosomes Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Medicinal Exosomes Sales Quantity by Type (2020-2031)
  • 7.2 North America Medicinal Exosomes Sales Quantity by Application (2020-2031)
  • 7.3 North America Medicinal Exosomes Market Size by Country
    • 7.3.1 North America Medicinal Exosomes Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Medicinal Exosomes Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Medicinal Exosomes Sales Quantity by Type (2020-2031)
  • 8.2 Europe Medicinal Exosomes Sales Quantity by Application (2020-2031)
  • 8.3 Europe Medicinal Exosomes Market Size by Country
    • 8.3.1 Europe Medicinal Exosomes Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Medicinal Exosomes Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medicinal Exosomes Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Medicinal Exosomes Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Medicinal Exosomes Market Size by Region
    • 9.3.1 Asia-Pacific Medicinal Exosomes Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Medicinal Exosomes Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Medicinal Exosomes Sales Quantity by Type (2020-2031)
  • 10.2 South America Medicinal Exosomes Sales Quantity by Application (2020-2031)
  • 10.3 South America Medicinal Exosomes Market Size by Country
    • 10.3.1 South America Medicinal Exosomes Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Medicinal Exosomes Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medicinal Exosomes Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Medicinal Exosomes Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Medicinal Exosomes Market Size by Country
    • 11.3.1 Middle East & Africa Medicinal Exosomes Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Medicinal Exosomes Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Medicinal Exosomes Market Drivers
  • 12.2 Medicinal Exosomes Market Restraints
  • 12.3 Medicinal Exosomes Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medicinal Exosomes and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medicinal Exosomes
  • 13.3 Medicinal Exosomes Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medicinal Exosomes Typical Distributors
  • 14.3 Medicinal Exosomes Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medicinal Exosomes. Industry analysis & Market Report on Medicinal Exosomes is a syndicated market report, published as Global Medicinal Exosomes Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Medicinal Exosomes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report